Review Article

Essentials of a Robust Deep Learning System for Diabetic Retinopathy Screening: A Systematic Literature Review

Table 3

Sensitivity, specificity, and AUC validation results of the 15 included studies. Differences in target condition and grading scales made direct comparisons of validation results difficult. AUC = area under the receiver operating characteristic curve; CI = confidence interval; DMO = diabetic macular oedema; DR = diabetic retinopathy; ETDRS = Early Treatment Diabetic Retinopathy Study; ICDR = International Clinical Diabetic Retinopathy Disease Severity Scale; NHS = English National Health Service; NZ MoH = New Zealand Ministry of Health.

% (95% CI)
SensitivitySpecificityAUC (95% CI)Target conditionDR grading scale

Gulshan et al. [24]97.5 (95.8–98.7)93.4 (92.8–94.0)Moderate or worse DR, referable DMO, or bothICDR
Gulshan et al. [32]92.1 (90.1–93.8)95.2 (94.2–96.1)0.980Moderate or worse DRICDR
Krause et al. [33]97.192.30.986Moderate or worse DRICDR
Ruamviboonsuk et al. [34]96.8 (93.9–100)95.6 (98.3–96.8)0.987 (0.977–0.995)Moderate or worse DRICDR
Voets et al. [35]90.684.70.951 (0.947–0.956)Moderate or worse DRICDR
Ramachandran et al. [36]96.090.00.980 (0.973–0.986)Moderate or worse DR, or exudates in 1 disc diameter of the foveaICDR and NZ MoH guidelines
Li et al. [37]97.091.40.989Preproliferative or worse DR, DMO, or bothNHS diabetic eye screening guidelines
Gargeya et al. [38]93.087.00.940No DR or any DR
Abràmoff et al. [39]96.8 (93.3–98.8)87.0 (84.2–89.4)0.980 (0.968–0.992)Moderate or worse DR, DMO, or bothICDR
Verbraak et al. [40]79.4 (66.5–87.9)93.8 (92.1–94.9)More than mild DRICDR
Abràmoff et al. [41]87.2 (81.8–91.2)90.7 (88.3–92.7)More than mild, or DMO, or bothETDRS
Ting et al. [42]98.9 (97.5–99.6)92.2 (89.5–94.3)0.983 (0.972–0.991)Moderate or worse DR, DMO, and/or ungradable imageICDR
Bellemo et al. [43]92.3 (90.1–94.1)89.0 (87.9–90.3)0.973 (0.969–0.978)Moderate or worse DR, DMO, and/or ungradable imageICDR
Rogers et al. [44]93.4% (95% CI: 90.8–95.8)94.2% (95% CI: 91.0–97.2)98.5% (95% CI: 97.8–99.2)Referable DR (RDR) and proliferative DR (PDR)Scottish DR grading scheme
Bhaskaranand et al. [45]91.3% (95% CI: 90.9%–91.7%)91.1% (95% CI: 90.9%–91.3%)0.965 (95% CI: 0.963–0.966)Severe NPDR, proliferative DRAmerican academy of ophthalmology